Skin Tone Measurement Method Investigation for Pulse Oximetry

The primary objective is to gather missing information in order to form a well-founded recommendation on which is the preferred skin pigmentation measurement (PPM) methods in the context of pulse-oximetry.

Study Overview

Status

Completed

Detailed Description

Skin tone bias in pulse-oximetry (SpO2) needs to be addressed urgently. While skin pigmentation is a prime candidate for the root cause of skin tone bias in SpO2, more research is needed. F A solid comparison and recommendation requires evaluation of several additional aspects that affect accuracy, precision, and reproducibility of the PMMs.

Briefly, these additional aspects that are evaluated in this study are listed below:

  • operator bias
  • impact of operator color blindness
  • probe pressure
  • probe aperture size
  • device stability
  • impact of blood on pigmentation measurement
  • feasibility of skin tone measurement on sides of fingers
  • intra-operator variability

PMMs included in this study are:

Subjective color matching methods by using:

  1. Von Luschan color scale
  2. Fitzpatrick color scale
  3. Pantone color scale

Objective probe-based measurements by using:

  1. Konica Minolta CM700d (reflectance spectrometer)
  2. Mx18 (erythema-melanin meter)
  3. SPA99 (erythema-melanin meter)

Measurements will be performed on 5 relatively light skinned, and 5 relatively dark skinned volunteers (N=10 in total*). The study will be executed on the High-Tech Campus Eindhoven (Netherlands) and each participant will have 3 visits of approximately 1.5 to 2 hours/visit.

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Healthy volunteers with Von Luschan scores <18 ('light skin' group) or > 25 ('dark skin' group.

Description

Inclusion Criteria:

  1. Adults (18-65 years)
  2. Fluent in either English or Dutch
  3. Participants who are willing and able to provide informed consent themselves.
  4. People with Von Luschan scores <18 ('light skin' group) or > 25 ('dark skin' group).

Exclusion Criteria:

  1. Skin conditions that could potentially interfere with the measurements:

    • piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
    • vascular or pigmentary or renal psoriasis
    • epidermal bullosum
    • other diseases that affect the skin (tone) of the body
  2. COVID-19 exclusion criteria*:

    • Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
    • Having been positively tested as infected with COVID-19 in the past 14 days
    • Travelled to or from high risk COVID-19 areas in the past 14 days
    • Been in contact with a (suspected) COVID-infected person in the past 14 days
  3. Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
  4. Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
  5. Known allergic reaction to facial make-up
  6. Usage of tanning sprays/cremes
  7. Wearing make-up during the study visits (mascara is allowed)

    • No testing will be performed in the study. Participants will be asked if they have been positively tested.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preferred skin PMM in the context of pulse-oximetry.
Time Frame: 10 months
The primary objective is to complement a previous skin pigmentation study executed by Philips to gather missing information in order to form a well-founded recommendation on which is the preferred skin PPM in the context of pulse-oximetry.
10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2023

Primary Completion (Actual)

April 11, 2023

Study Completion (Actual)

April 11, 2023

Study Registration Dates

First Submitted

December 12, 2022

First Submitted That Met QC Criteria

December 12, 2022

First Posted (Actual)

December 20, 2022

Study Record Updates

Last Update Posted (Actual)

April 12, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ICBE-S-000880

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The plan is to perform data analysis by Philips Research. Thereafter data will be shared (de-identified) in a seperate publication that can be accessed overall.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulse Oximetry

Clinical Trials on Observational measurements of skin tone

3
Subscribe